Clinical Research Directory
Browse clinical research sites, groups, and studies.
iTBS for Increased Appetite Induced by Antipsychotics
Sponsor: Central South University
Summary
Antipsychotics are prone to cause metabolic side effects, including weight gain, hyperglycemia, insulin resistance, hyperlipidemia and so on, leading to a 2-3 times higher risk of death in patients with schizophrenia compared to healthy people. Conventional high-frequency rTMS have been used to treat people with obesity and showed certain effectiveness. However, studies involving schizophrenia patients and intermittent theta burst (iTBS) mode are rarely seen. The goal of this clinical trial is to evaluate the efficacy and safety of iTBS on ameliorating increased appetite induced by antipsychotics in people with schizophrenia.
Official title: Effects of Intermittent Theta Burst Stimulation (iTBS) on Increased Appetite Induced by Antipsychotics in Patients With Schizophrenia
Key Details
Gender
All
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-08-01
Completion Date
2026-08-01
Last Updated
2025-03-26
Healthy Volunteers
No
Conditions
Interventions
Active iTBS
Mag-TD
Sham iTBS
Mag-TD
Locations (2)
Central South University
Changsha, Hunan, China
The Second People's Hospital of Dali Bai Autonomous Prefecture
Dali, Yunnan, China